EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brás-Silva, C.
Right arrow Articles by Leite-Moreira, A. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brás-Silva, C.
Right arrow Articles by Leite-Moreira, A. F.
Experimental Biology and Medicine 231:893-898 (2006)
© 2006 Society for Experimental Biology and Medicine


HEART

Impaired Response to ETB Receptor Stimulation in Heart Failure: Functional Evidence of Endocardial Endothelial Dysfunction?

Carmen Brás-Silva, Ana Patrícia Fontes-Sousa, Cláudia Moura, José Carlos Areias and Adelino F. Leite-Moreira1

Department of Physiology, Faculty of Medicine, University of Porto, Portugal

To whom requests for reprints should be addressed at 1 Department of Physiology, Faculty of Medicine, Alameda Professor Hernâni Monteiro, 4200–319 Porto, Portugal. E-mail: amoreira{at}med.up.pt

Abstract

Inotropic effects of selective ETB receptor stimulation depend on the functional integrity of the endocardial endothelium (EE), which is negative when it is intact and positive when it is damaged. These results have been attributed to the existence of two subtypes of ETB receptors in the heart: (i) ETB1, located on the EE, decreases inotropy; (ii) ETB2, located on myocardial cells, increases inotropy. In the present study we investigated the functional integrity of the EE in a heart failure (HF) model (doxorubicin-induced cardiomyopathy) by evaluating the contractile response to ETB1 receptor stimulation. New Zealand White rabbits were treated with doxorubicin (DOX-HF, 1 mg/kg, iv, twice weekly for 8 weeks) or with saline. Contractile effects of increasing doses of a selective agonist of endothelial ETB receptors, IRL-1620 (10–9 to 10–6 M), were studied in papillary muscles (Krebs-Ringer: 1.8 mM CaCl2, 35°C) from control (n = 10) and DOX-HF rabbits (n = 7). Isotonic and isometric twitches were recorded and analyzed. Reported parameters included active tension (AT) and maximum velocities of tension rise (dT/dtmax) and decline (dT/dtmin). On echocardiography, DOX-HF rabbits had increased left ventricular (LV) end-diastolic and end-systolic diameters and reduced ejection fraction (52% ± 2% vs. 61% ± 1%). Contrary to control papillary muscles, DOX-HF muscles showed a steady decrease in contractility between 1 and 4 Hz. In the control group, IRL-1620 induced dose-dependent negative inotropic and lusitropic effects that decreased at 10–6 M: 26% ± 3%, AT; 17% ± 3%, dT/dtmax; and 16% ± 5%, dT/dtmin. In the DOX-HF group, these effects were significantly reduced. At the same concentration, IRL-1620 decreased AT (8% ± 3%) and dT/dtmax (8% ± 3%), without significantly affecting dT/dtmin. This study showed an impaired response to endothelial ETB receptor stimulation, providing for the first time strong evidence of the occurrence of EE dysfunction in the failing heart and further highlighting the potential use of ETB receptor stimulation as a marker of EE function.

Key Words: heart • endothelin • endothelial function • ETB receptors • contractile function • heart failure







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Society for Experimental Biology and Medicine.